Marshall Wace’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Buy
+22,248
New +$3.3M ﹤0.01% 1463
2025
Q4
Sell
-25,684
Closed -$2.51M 2907
2025
Q3
$2.51M Buy
+25,684
New +$2.07M ﹤0.01% 1502
2025
Q1
Sell
-45,118
Closed -$3.15M 2580
2024
Q4
$3.15M Sell
45,118
-140,554
-76% -$11.7M ﹤0.01% 1267
2024
Q3
$19.5M Buy
185,672
+165,021
+799% +$19.3M 0.02% 518
2024
Q2
$2.94M Sell
20,651
-62,217
-75% -$7.17M ﹤0.01% 1206
2024
Q1
$9.24M Buy
82,868
+80,281
+3,103% +$9.57M 0.01% 772
2023
Q4
$336K Buy
+2,587
New +$357K ﹤0.01% 1854
2023
Q1
Sell
-7,769
Closed -$617K 2592
2022
Q4
$617K Buy
+7,769
New +$547K ﹤0.01% 2293
2022
Q3
Sell
-27,534
Closed -$1.51M 3280
2022
Q2
$1.51M Buy
+27,534
New +$1.6M ﹤0.01% 2184
2019
Q4
Sell
-34,586
Closed -$591K 1647
2019
Q3
$591K Buy
+34,586
New +$553K ﹤0.01% 1064
2018
Q4
Sell
-67,852
Closed -$1.33M 1559
2018
Q3
$1.33M Buy
+67,852
New +$1.4M 0.01% 754

Other funds holding ACLS

Marshall Wace's ACLS Position: Q2 2026 in Review

Marshall Wace opened a new position in Axcelis (ACLS) in Q2 2026: 22,248 shares worth $4.21M. The stake represents ﹤0.01% of the portfolio and ranks #1463 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ACLS as recently as Q3 2025.

Marshall Wace first reported a position in ACLS in Q3 2018 and has held it in 11 quarters since. The position peaked at $19.5M in Q3 2024. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Marshall Wace held 22,248 shares of Axcelis worth $4.21M as of Q2 2026.
  • Axcelis was a new Marshall Wace position in Q2 2026.
  • Axcelis made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1463 holding.
  • Marshall Wace first reported a position in Axcelis in Q3 2018 and has held it in 11 quarters since.
  • Marshall Wace's Axcelis position peaked at $19.5M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.